Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sarepta Therapeutics

61.56
+0.04500.07%
Volume:426.70K
Turnover:26.33M
Market Cap:5.97B
PE:26.33
High:62.11
Open:61.37
Low:60.87
Close:61.51
Loading ...

Sarepta Therapeutics Shares Down 26% Premarket; Co Reports Patient Death Following Treatment With Its Gene Therapy

THOMSON REUTERS
·
18 Mar

Sarepta says patient dies after treatment with gene therapy

Reuters
·
18 Mar

Sarepta Therapeutics- Man With Duchenne Muscular Dystrophy Passed Away Following Treatment With Elevidys, Having Suffered Acute Liver Failure

THOMSON REUTERS
·
18 Mar

Sarepta Therapeutics: Patient Had Recent Cmv Infection Which Was Identified as Possible Contributing Factor

THOMSON REUTERS
·
18 Mar

Sarepta Therapeutics : Intends to Update Prescribing Information to Appropriately Represent This Event

THOMSON REUTERS
·
18 Mar

S&P 500 Futures Fall In Premarket Trading; Sarepta Therapeutics, Trex Co Lag

Dow Jones
·
18 Mar

Evercore ISI Reaffirms Their Buy Rating on Sarepta Therapeutics (SRPT)

TIPRANKS
·
18 Mar

Sarepta Therapeutics Initiated at Sector Perform by Scotiabank

Dow Jones
·
08 Mar

SLDB Stock Rallies 60% in a Month: Here's What You Should Know

Zacks
·
07 Mar

Sarepta initiated with a Sector Perform at Scotiabank

TIPRANKS
·
07 Mar

Exploring 3 High Growth Tech Stocks In The US Market

Simply Wall St.
·
07 Mar

Statutory Earnings May Not Be The Best Way To Understand Sarepta Therapeutics' (NASDAQ:SRPT) True Position

Simply Wall St.
·
07 Mar

Spotting Winners: Sarepta Therapeutics (NASDAQ:SRPT) And Therapeutics Stocks In Q4

StockStory
·
04 Mar

Stock Track | Sarepta Therapeutics Plummets 6.14% on Mixed Shelf Offering Plans

Stock Track
·
04 Mar

BRIEF-Sarepta Therapeutics Inc Files For Mixed Shelf Size Not Disclosed

Reuters
·
04 Mar

Sarepta Therapeutics Inc Files for Mixed Shelf; Size Not Disclosed - SEC Filing

THOMSON REUTERS
·
04 Mar

Stock Track | Sarepta Therapeutics Soars 5% After Announcing Scholarship Program and Upbeat Earnings

Stock Track
·
28 Feb

Sarepta Therapeutics Announces Call for Applications for the 8TH Annual Route 79, the Duchenne Scholarship Program

THOMSON REUTERS
·
28 Feb

Sarepta Therapeutics Announces Call for Applications for the 8th Annual Route 79, The Duchenne Scholarship Program

Business Wire
·
28 Feb

Sarepta Therapeutics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.
·
28 Feb